Biotech · Private company
Aptinyx
Track this companyFree. Adds Aptinyx to your Dealase workspace and tells you when its record changes.
Clinical trials71 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- NYX-783Phase 3 · PTSDClinicalTrials.gov · fetched Nov 12, 2026
- NYX-2925Phase 2 · Diabetic Peripheral NeuropathyClinicalTrials.gov · fetched Nov 12, 2026
- NYX-2925Phase 2 · FibromyalgiaClinicalTrials.gov · fetched Nov 12, 2026
- NYX-2925 50 mgPhase 2 · Diabetic Peripheral Neuropathic PainClinicalTrials.gov · fetched Nov 12, 2026
- NYX-458Phase 2 · Mild Cognitive ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- NYX-783Phase 2 · Post-Traumatic Stress DisorderClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- Safety and Efficacy of 50 mg NYX-783 QD vs. Placebo in PTSDPHASE2_PHASE3 · TERMINATED · started Dec 13, 2021ClinicalTrials.gov NCT05181995 · fetched Nov 12, 2026
- NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking)PHASE2 · ACTIVE_NOT_RECRUITING · started Nov 14, 2019ClinicalTrials.gov NCT04148391 · fetched Nov 12, 2026
- Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)PHASE2 · COMPLETED · started Nov 12, 2019ClinicalTrials.gov NCT04146896 · fetched Nov 12, 2026
- Efficacy and Safety of NYX-2925 in Subjects With FibromyalgiaPHASE2 · COMPLETED · started Nov 12, 2019ClinicalTrials.gov NCT04147858 · fetched Nov 12, 2026
- Safety and Efficacy of NYX-783 in Subjects With Post-Traumatic Stress DisorderPHASE2 · COMPLETED · started Jan 25, 2019ClinicalTrials.gov NCT04044664 · fetched Nov 12, 2026
- Evaluate the Efficacy and Safety of NYX-2925 in Subjects With FibromyalgiaPHASE2 · COMPLETED · started Aug 14, 2017ClinicalTrials.gov NCT03249103 · fetched Nov 12, 2026
- Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral NeuropathyPHASE2 · COMPLETED · started Jun 27, 2017ClinicalTrials.gov NCT03219320 · fetched Nov 12, 2026